Imitation Training for Autism
(EMIT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to develop a new method to help young children with autism learn imitation skills, which are crucial for their development. The treatment, called Emergent Multi-Class Imitation Training (EMIT), focuses on teaching various types of imitation, such as copying movements or using objects. Based on research from the last five decades, it seeks to help children generalize what they learn more easily. Children diagnosed with autism who are 5 years old or younger, without conditions affecting motor skills, might be suitable candidates. As an unphased trial, this study offers families a unique opportunity to contribute to pioneering research that could significantly enhance early developmental support for children with autism.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this protocol is safe for autistic children?
A previous study showed that Emergent Multi-Class Imitation Training (EMIT) helps autistic children improve their imitation skills. Research indicates that this training is generally well-tolerated, allowing most children to participate without major issues. It focuses on teaching various types of imitation, such as copying movements, using objects, and making sounds, which helps address the challenges autistic children face in learning and applying new skills.
EMIT involves no drugs, so there are no medication side effects. The training is designed to be safe and manageable for young children. While still under evaluation, early findings suggest that children benefit from it without experiencing negative effects.12345Why are researchers excited about this trial?
Researchers are excited about Emergent Multi-Class Imitation Training (EMIT) for autism because it takes a novel approach by focusing on improving imitation skills, which are often challenging for individuals with autism. Unlike standard treatments that might center on behavioral interventions or medication, EMIT specifically targets the capacity to mimic actions across multiple contexts, which is crucial for social learning and interaction. This method holds the potential to enhance communication and social skills more effectively by addressing a fundamental developmental skill, setting it apart from traditional therapies.
What evidence suggests that this protocol is effective for autism?
Research has shown that Emergent Multi-Class Imitation Training (EMIT) is grounded in nearly fifty years of studies on how autistic children learn through imitation. This training enhances skills such as movement and speech, which often pose challenges for autistic children. Studies have found that using proven methods to teach imitation can improve learning and classroom participation for these children. Although EMIT is new, it relies on well-researched techniques that have demonstrated benefits in helping children apply learned skills across various situations. While early data collection is ongoing, the strong research foundation of EMIT suggests it could benefit children with autism.12346
Who Is on the Research Team?
Meghan A Deshais, Ph.D.
Principal Investigator
Rutgers University
Are You a Good Fit for This Trial?
This trial is for children aged 5 or under who have been diagnosed with autism or are on the autism spectrum. They should score no more than 40 on a Motor Vocal Imitation Assessment and no more than 36 on the Peabody Picture Vocabulary Test-5, and must be able to match identical items above chance levels.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the EMIT intervention, which includes training in motor, object, and vocal imitation
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Emergent Multi-Class Imitation Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rutgers, The State University of New Jersey
Lead Sponsor